OFFICES IN Washington D.C. & New Delhi

The Center For Disease Dynamics, Economics & Policy

Areas of Research

CDDEP research focuses on four sets of questions as they apply to malaria, antibiotic resistance, disease control priorities, environmental health, alcohol and tobacco, and various other diseases.

Antibiotic Resistance

Discover the numerous ways we are addressing antibiotic effectiveness.

Learn More

Disease Control Priorities

Learn More

Environmental Health

Learn More


Read more about how we are combining medical intelligence and climate data to track malaria.

Learn More

Alcohol and Tobacco

Learn More

Health and Development

Learn More

Our research focuses on four sets of questions as they apply to these areas of research.
1. Disease Dynamics and Behavior

How are disease dynamics influenced by incentives and human behavior? In recent years, CDDEP researchers have expanded the frontiers of economic epidemiology—the interplay of ecology and economics in determining how infectious diseases emerge, establish, and spread—and will further develop this field. Strong multidisciplinary teams that include mathematical disease modelers and economists are the key to this work.

2. Information Structure and Disease Dynamics

What is the role of information in the spread of infectious diseases and how does it affect how we prevent and respond to disease outbreaks? What are countries’ incentives to look for and report disease outbreaks? What kind of international mechanisms could create incentives to improve surveillance and reporting and thereby improve control over the spread of disease and its effects?

3. Delivery of New Technologies for Disease Control

Drugs, vaccines, and diagnostic tests are the products of deliberate research and development streams, invariably involving both public and private sector funding and built-in incentives and disincentives. The value placed on new technologies depends on the perspective of the actor—governments, for-profit companies—but almost never takes the point of view of society as a whole, either national or global. How should new technologies be valued? How should they be compared with the conservation of any existing technologies? What changes in incentives are needed to achieve optimal levels of R&D for different products.

4. Innovative Financing

How can tools from public economics be applied to address externalities inherent in infectious diseases? AMFm is one such mechanism, using a global subsidy to address a public goods problem. What avenues exist for global health financing to address other externality problems, such as those confronted by immunization programs and efforts to reduce antibiotic overuse?